Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 3.63
(10.0%)
CNY 3.63
(10.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.47 Billion CNY | -12.12% |
| 2022 | 1.67 Billion CNY | 11.31% |
| 2021 | 1.5 Billion CNY | -14.61% |
| 2020 | 1.76 Billion CNY | -6.95% |
| 2019 | 1.89 Billion CNY | -26.12% |
| 2018 | 2.56 Billion CNY | 0.47% |
| 2017 | 2.55 Billion CNY | 6.54% |
| 2016 | 2.39 Billion CNY | 17.6% |
| 2015 | 2.03 Billion CNY | -1.63% |
| 2014 | 2.07 Billion CNY | 63.3% |
| 2013 | 1.26 Billion CNY | 73.44% |
| 2012 | 731.32 Million CNY | 9.89% |
| 2011 | 665.5 Million CNY | -3.38% |
| 2010 | 688.81 Million CNY | 20.58% |
| 2009 | 571.26 Million CNY | -7.95% |
| 2008 | 620.62 Million CNY | 1.7% |
| 2007 | 610.23 Million CNY | 8.53% |
| 2006 | 562.27 Million CNY | -13.85% |
| 2005 | 652.65 Million CNY | 80.74% |
| 2004 | 361.1 Million CNY | 31.35% |
| 2003 | 274.92 Million CNY | 57.22% |
| 2002 | 174.86 Million CNY | 29.36% |
| 2001 | 135.17 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.44 Billion CNY | -7.99% |
| 2024 Q3 | 1.39 Billion CNY | -4.11% |
| 2024 Q1 | 1.57 Billion CNY | 7.0% |
| 2023 Q1 | 1.73 Billion CNY | 3.74% |
| 2023 Q3 | 1.54 Billion CNY | -8.17% |
| 2023 Q4 | 1.47 Billion CNY | -4.98% |
| 2023 FY | 1.47 Billion CNY | -12.12% |
| 2023 Q2 | 1.68 Billion CNY | -2.92% |
| 2022 Q2 | 2.14 Billion CNY | 29.66% |
| 2022 Q3 | 2.04 Billion CNY | -4.59% |
| 2022 Q4 | 1.67 Billion CNY | -18.01% |
| 2022 FY | 1.67 Billion CNY | 11.31% |
| 2022 Q1 | 1.65 Billion CNY | 9.75% |
| 2021 Q4 | 1.5 Billion CNY | -18.12% |
| 2021 Q3 | 1.83 Billion CNY | 4.81% |
| 2021 FY | 1.5 Billion CNY | -14.61% |
| 2021 Q2 | 1.75 Billion CNY | -3.23% |
| 2021 Q1 | 1.81 Billion CNY | 2.81% |
| 2020 FY | 1.76 Billion CNY | -6.95% |
| 2020 Q1 | 1.83 Billion CNY | -3.14% |
| 2020 Q2 | 1.91 Billion CNY | 4.31% |
| 2020 Q3 | 2.25 Billion CNY | 17.78% |
| 2020 Q4 | 1.76 Billion CNY | -21.8% |
| 2019 Q3 | 1.6 Billion CNY | -11.7% |
| 2019 Q2 | 1.82 Billion CNY | -9.25% |
| 2019 Q1 | 2 Billion CNY | -21.71% |
| 2019 FY | 1.89 Billion CNY | -26.12% |
| 2019 Q4 | 1.89 Billion CNY | 17.77% |
| 2018 Q3 | 2.59 Billion CNY | 1.65% |
| 2018 FY | 2.56 Billion CNY | 0.47% |
| 2018 Q4 | 2.56 Billion CNY | -1.17% |
| 2018 Q2 | 2.55 Billion CNY | -3.41% |
| 2018 Q1 | 2.64 Billion CNY | 3.55% |
| 2017 FY | 2.55 Billion CNY | 6.54% |
| 2017 Q1 | 2.36 Billion CNY | -1.19% |
| 2017 Q2 | 2.04 Billion CNY | -13.71% |
| 2017 Q3 | 2.28 Billion CNY | 11.64% |
| 2017 Q4 | 2.55 Billion CNY | 11.93% |
| 2016 Q3 | 2.35 Billion CNY | 21.13% |
| 2016 FY | 2.39 Billion CNY | 17.6% |
| 2016 Q1 | 1.93 Billion CNY | -5.26% |
| 2016 Q2 | 1.94 Billion CNY | 0.9% |
| 2016 Q4 | 2.39 Billion CNY | 1.57% |
| 2015 Q4 | 2.03 Billion CNY | 26.22% |
| 2015 Q2 | 1.45 Billion CNY | -19.04% |
| 2015 Q1 | 1.8 Billion CNY | -12.94% |
| 2015 FY | 2.03 Billion CNY | -1.63% |
| 2015 Q3 | 1.61 Billion CNY | 10.57% |
| 2014 FY | 2.07 Billion CNY | 63.3% |
| 2014 Q3 | 1.77 Billion CNY | 48.62% |
| 2014 Q4 | 2.07 Billion CNY | 16.88% |
| 2014 Q2 | 1.19 Billion CNY | 12.81% |
| 2014 Q1 | 1.05 Billion CNY | -16.67% |
| 2013 FY | 1.26 Billion CNY | 73.44% |
| 2013 Q4 | 1.26 Billion CNY | 43.89% |
| 2013 Q1 | 583.08 Million CNY | -20.27% |
| 2013 Q2 | 748.11 Million CNY | 28.3% |
| 2013 Q3 | 881.49 Million CNY | 17.83% |
| 2012 Q4 | 731.32 Million CNY | 23.04% |
| 2012 Q2 | 623.46 Million CNY | 0.56% |
| 2012 Q1 | 619.99 Million CNY | -6.84% |
| 2012 FY | 731.32 Million CNY | 9.89% |
| 2012 Q3 | 594.37 Million CNY | -4.67% |
| 2011 FY | 665.5 Million CNY | -3.38% |
| 2011 Q4 | 665.5 Million CNY | 24.04% |
| 2011 Q3 | 536.51 Million CNY | -8.16% |
| 2011 Q2 | 584.19 Million CNY | -6.08% |
| 2011 Q1 | 622.03 Million CNY | -9.69% |
| 2010 FY | 688.81 Million CNY | 20.58% |
| 2010 Q1 | 521.66 Million CNY | -8.68% |
| 2010 Q2 | 627.44 Million CNY | 20.28% |
| 2010 Q3 | 587.48 Million CNY | -6.37% |
| 2010 Q4 | 688.81 Million CNY | 17.25% |
| 2009 Q2 | 492.74 Million CNY | -1.9% |
| 2009 Q4 | 571.26 Million CNY | -2.02% |
| 2009 Q3 | 583.03 Million CNY | 18.32% |
| 2009 Q1 | 502.26 Million CNY | -19.07% |
| 2009 FY | 571.26 Million CNY | -7.95% |
| 2008 Q4 | 620.62 Million CNY | 15.67% |
| 2008 FY | 620.62 Million CNY | 1.7% |
| 2008 Q1 | 548.08 Million CNY | -10.18% |
| 2008 Q2 | 530.86 Million CNY | -3.14% |
| 2008 Q3 | 536.56 Million CNY | 1.07% |
| 2007 Q3 | 525.17 Million CNY | -14.17% |
| 2007 Q1 | 584.95 Million CNY | 4.03% |
| 2007 FY | 610.23 Million CNY | 8.53% |
| 2007 Q2 | 611.84 Million CNY | 4.6% |
| 2007 Q4 | 610.23 Million CNY | 16.2% |
| 2006 Q2 | 511.45 Million CNY | -18.44% |
| 2006 Q1 | 627.05 Million CNY | -3.92% |
| 2006 Q4 | 562.27 Million CNY | -2.04% |
| 2006 FY | 562.27 Million CNY | -13.85% |
| 2006 Q3 | 573.98 Million CNY | 12.23% |
| 2005 Q3 | 381.84 Million CNY | 4.12% |
| 2005 Q4 | 652.65 Million CNY | 70.92% |
| 2005 Q1 | 335.13 Million CNY | -7.19% |
| 2005 FY | 652.65 Million CNY | 80.74% |
| 2005 Q2 | 366.72 Million CNY | 9.43% |
| 2004 Q4 | 361.1 Million CNY | 36.6% |
| 2004 Q2 | 264.11 Million CNY | -15.48% |
| 2004 FY | 361.1 Million CNY | 31.35% |
| 2004 Q1 | 312.46 Million CNY | 13.65% |
| 2004 Q3 | 264.35 Million CNY | 0.09% |
| 2003 Q4 | 274.92 Million CNY | 0.0% |
| 2003 FY | 274.92 Million CNY | 57.22% |
| 2002 FY | 174.86 Million CNY | 29.36% |
| 2001 FY | 135.17 Million CNY | 0.0% |